Skip to content
Home/Companies/Healthcare/Glycovaxin
GL

Glycovaxin

Healthcare·France·Exited 2015·Held 6yr

Glycovaxin is a healthcare company, headquartered in France.

Entry
2009
Hold
6yr
Exit
2015
Est. EV
–

Who owns Glycovaxin?

Glycovaxin was owned by Andera Partners through BioDiscovery 3 (2009 vintage) from 2009 to 2015, exited via Trade Sale.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 3 · 2009 · VC

Key facts

HQFrance
SectorHealthcare
Exit Type
Trade Sale
Buyer
–
MOIC
–
Exit Year
2015

More from BioDiscovery 3

Other portfolio companies in the same fund.

Cellnovo
Exited 2015
HealthcareFrance· 2011
GenKyoTex
Exited 2014
HealthcareFrance· 2011
Sapiens
Exited 2013
HealthcareFrance· 2011
to
Covagen
Exited 2014
HealthcareFrance· 2010
to
Parvulus Medical
Exited
HealthcareFrance· 2010
Poxel
Active
HealthcareFrance· 2010

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings